[On the incidence of ocular disorders in severe migraine, common migraine and migraine states. Evaluation of the results obtained with medical and oculistic therapy].
D000293:Adolescent; D000328:Adult; D001251:Astigmatism / Q000150:complications; D003533:Cyproheptadine / Q000627:therapeutic use*; D005128:Eye Diseases / Q000150:complications*; D005260:Female; D005901:Glaucoma / Q000150:complications; D006801:Humans; D006956:Hyperopia / Q000150:complications; D008297:Male; D008784:Methysergide / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000209:etiology* / Q000628:therapy; D009216:Myopia / Q000150:complications; D011305:Presbyopia / Q000150:complications; D013285:Strabismus / Q000150:complications
D003533:Cyproheptadine; D008784:Methysergide
Considerazioni sull'incidenza delle affezioni oculistiche nella grande emicrania, nell'emicrania comune e nello stato di male emicranico. Valutazione dei risultati ottenuti dalla terapia medica ed oculistica.